Michael O'Flynn is an R&D Regulatory Transformation Programme Director and Global Head of Regulatory Project Management for Oncology at AstraZeneca. They have extensive experience in regulatory affairs, previously serving in various leadership roles at GlaxoWellcome and AstraZeneca. Michael began their career as a Research Officer at Hammersmith Hospital, where they focused on radioimmunoassay research and published papers. They hold a BA in Biochemistry from Trinity College Dublin and an MSc in BioPharmacy from King's College London.
This person is not in any teams
This person is not in any offices